Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
69M
-
Number of holders
-
55
-
Total 13F shares, excl. options
-
34.8M
-
Shares change
-
+34.8M
-
Total reported value, excl. options
-
$1.64B
-
Value change
-
+$1.64B
-
Number of buys
-
54
-
Price
-
$48.08
Significant Holders of Olema Pharmaceuticals, Inc. - Common Stock (OLMA) as of Q4 2020
55 filings reported holding OLMA - Olema Pharmaceuticals, Inc. - Common Stock as of Q4 2020.
Olema Pharmaceuticals, Inc. - Common Stock (OLMA) has 55 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34.8M shares
of 69M outstanding shares and own 50.48% of the company stock.
Largest 10 shareholders include BVF INC/IL (6.66M shares), Logos Global Management LP (3.74M shares), JANUS HENDERSON GROUP PLC (3.64M shares), Cormorant Asset Management, LP (3.2M shares), RA CAPITAL MANAGEMENT, L.P. (2.15M shares), WELLINGTON MANAGEMENT GROUP LLP (2.07M shares), VR Adviser, LLC (1.54M shares), CITADEL ADVISORS LLC (1.43M shares), Vivo Capital, LLC (1.24M shares), and Avoro Capital Advisors LLC (877K shares).
This table shows the top 55 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.